John M. Evans, CEO: Beam Therapeutics BEAM Sell · Filed 02/02

Trade details

Type: Insider sale
Amount: $624,597.38
Shares · price: 22,094 sh · $28.27 a share
Held after: 989,573 sh
Stock: Beam Therapeutics BEAM
Person: John M. EvansCEO
Trade date: 26/01/30
Filed: 26/02/02
Days to filing: 3 days

Sold 2.2% of holdings

Share of holding sold: 2.2%

Beam Therapeutics trades, last 26 weeks

What else happened in Beam Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/31~03/01

John M. Evans's recent trades

John M. EvansCEO
Planned sale10b5-1 planBeam Therapeutics
Planned sale10b5-1 plan
Beam Therapeutics
BEAM
$857.7K
25,000 sh
$857.7K
Filed 06/30
Traded 06/30
John M. EvansCEO
Planned sale10b5-1 planBeam Therapeutics
Planned sale10b5-1 plan
Beam Therapeutics
BEAM
$887.4K
25,000 sh
$887.4K
Filed 06/29
Traded 06/29
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$739.3K
30,078 sh
$739.3K
Filed 04/06
Traded 04/01
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$569K
25,000 sh
$569K
Filed 04/01
Traded 03/31
John M. EvansCEO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$559.3K
25,000 sh
$559.3K
Filed 04/01
Traded 03/30

John M. Evans, CEO — sold $624.6K of Beam Therapeutics BEAM · 2.2% of holdings · 10b5-1 plan | Whalegun